OP016: Mini-COMET: Safety and efficacy of ≥97 weeks’ avalglucosidase alfa in infantile-onset Pompe disease participants previously treated with alglucosidase alfaDavid Kronn, On behalf of the Mini-COMET investigators, Anaïs Brassier et al.|Genetics in Medicine|2022Cited by 10